行情

AEMD

AEMD

Aethlon Med
NASDAQ

实时行情|Nasdaq Last Sale

2.937
-0.243
-7.63%
已收盘, 16:00 11/18 EST
开盘
3.050
昨收
3.180
最高
3.300
最低
2.919
成交量
8,119
成交额
--
52周最高
26.10
52周最低
3.038
市值
423.36万
市盈率(TTM)
-0.0332
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AEMD 新闻

  • 沪指低开高走 鲍威尔同特朗普及美财长会晤
  • 新浪财经.34分钟前
  • 美联储梅斯特:当前货币政策“适当” 将观望经济发展
  • 新浪财经综合.6小时前
  • 数万人将失业 日本大型银行为削减成本拟加速裁员
  • 中国新闻网.6小时前
  • 独角兽企业WeWork拟裁员自救 涉及超4000人
  • 新京报网.6小时前

更多

所属板块

先进医疗设备和技术
-0.99%
医疗设备和用品
-0.74%

热门股票

名称
价格
涨跌幅

AEMD 简况

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.
展开

Webull提供Aethlon Medical, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。